Browsing Tag
Etcamah
2 posts
Guardant360 enters a new breast cancer workflow built on testing every three months
Guardant Health has secured FDA approval for Guardant360 CDx as the companion diagnostic for AstraZeneca’s Etcamah, introducing repeated liquid-biopsy testing during first-line metastatic breast cancer therapy.
FDA advisers voted 6-3 against AstraZeneca’s breast cancer strategy. The drug was just approved anyway
The U.S. Food and Drug Administration has granted accelerated approval to AstraZeneca’s Etcamah after a Phase III trial showed a 56% reduction in progression or death, creating the first U.S. cancer treatment strategy triggered by a resistance mutation found in blood before imaging shows disease progression.